Solving the puzzle that ties mitral valve prolapse (MVP) to sudden cardiac death (SCD) necessarily means overcoming two central challenges: establishing a mechanistic association between a very common disorder (MVP) and a rare outcome (SCD) and discerning the cause and effect of an increasing array of associated structural, electrocardiographic, and now pathological findings. 
In this issue of

The Second Hit
A tenable assumption, given the widespread prevalence of MVP, is that when sudden death occurs, the typically innocent valvular abnormality is a bystander with no pathogenic significance. However, researchers in this field have cyclically readdressed a possible link with a series of anecdotes and retrospective analyses. This would appear as futile an endeavor as trying to link gray hair to the risk of developing atypical atrial flutter, except for the fact that the population of interest, as is the one studied by Basso, 1 is young, otherwise healthy and should not be dying suddenly. Given that MVP is so common, it seems likely that patients who develop malignant arrhythmia have a second, unrelated proarrhythmic factor that (although by itself may be relatively benign) creates a potentially fatal admixture of trigger and substrate. In a recent report, benign outflow tract ectopy was associated with malignant MVP syndrome. 2 Both entities valve prolapse and complex ventricular arrhythmia) and suitable control groups, t t the he hey y y re re repo po port rt rt pathological and MRI findings that strongly suggest arrhythmogenic substrate in the region of he mi mi mitr tr tral al al v v val al alve a a ap pp pparatus that may explain a hith th ther er erto t missing link betwe we ween e e MVP and SCD.
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Chickens and Egg
Several other potential pathogenic risk factors with MVP have been explored in trying to explain why only a minority of patients have major arrhythmia. Bileaflet MVP was found in 70% of affected patients in the present study and was nearly universal in a prior report. 2 Complex ectopy, including nonsustained arrhythmia and now the fibrosis/scar reported by Basso et al 1 may well be the differentiating factors for malignant outcomes. However, defining these associations as causative is problematic. For example, in fetal development, dysplastic and progressive changes in the perimitral apparatus may be the forerunner for myxomatous prolapsing leaflets and not vice versa. 3 Similarly, complex ectopy may exaggerate the amount of regurgitation or prolapse detected with echocardiography done during arrhythmia.
Pushes and Pull
The structural changes noted around the mitral valve apparatus could be, as pointed out by Basso et al, 1 a result of increased tension on the chordae and transmission of this force to the mitral support apparatus. However, perhaps equally important are the contact lesions that result from the redundant valve prolapsing into the atrium in systole and snapping back against the ventricular myocardium during diastole. The difference between these mechanisms is more than semantic, since while stretch may produce fibrotic changes and abnormal substrate, excessive contact may do the same but also represent a mechanical triggering source for PVCs that may set off ventricular arrhythmias.
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Regionality
A unique finding in the present study is that the "second hit" discussed above (scarring and possibly mechanical triggers) may well arise from the first hit (mitral valve prolapse) itself.
Striking is the regionality of the structural changes at MRI and autopsy. On pathology, 88% of sudden death victims have fibrosis in the papillary muscle or inferobasal portions of the LV, and on MRI, 93% of patients with complex arrhythmia had scarring in this region. We do not know the clinical follow up of these potentially abnormal controls, but presumably, the structural abnormalities may precede clinically manifest severe arrhythmias.
Electrocardiographic Abnormalities
Abnormal T waves were clearly evident, and were present in 10 of 12 of their patients who had
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Basso et al 1 have clearly demonstrated that MVP is common among those who die suddenly (13% of young females in their autopsy series), and that findings of fibrosis are common. This study is a veritable catechization for cardiac epidemiologists and electrophysiologists to find best ways to effectively identify patients at risk and prevent their untimely death from malignant arrhythmia. To answer these summons, we need to acknowledge that with retrospective studies, we cannot unravel this Gordian knot but rather we need to cut it (surgically treat less severe forms of MVP) or ablate it (the abnormal fibrotic and heterogenous substrate) and determine in large prospective studies whether we can have positive impact on the natural history of malignant MVP. Until such time it may be prudent in patients with MVP and perimitral annular and papillary muscle related complex arrhythmias to consider MRI and possibly EP study for risk stratification. Indeed Basso et al's findings 1 now make it difficult to universally reassure patients with MVP and previously considered benign non-sustained ventricular arrhythmia.
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